scholarly journals Metabolic regulation in the immune response to cancer

2021 ◽  
Author(s):  
Qi Wu ◽  
Xin Yu ◽  
Juanjuan Li ◽  
Shengrong Sun ◽  
Yi Tu
1978 ◽  
Vol 87 (1) ◽  
pp. 138-141 ◽  
Author(s):  
Charles J. Krause ◽  
John O. Nysather

It is apparent that development of consistently effective methods of immunotherapy must await a more thorough understanding of the immune response to cancer. However, even those forms of immunotherapy which have been developed to date indicate a tremendous potential. It appears that immunotherapy may be most useful as an adjuvant to established forms of treatment. Surgery, radiation therapy and/or chemotherapy are used to remove all of the gross tumor, with immune therapy then employed to destroy the small foci of tumor which remain. As methods are developed which are effective in counteracting the immunosuppression of tumors, other means of immunotherapy may be found which are capable of destroying tumor cells while not affecting the adjacent normal tissue. Thus, the future of immune therapy holds great promise. As more is learned about the immune response to cancer, advances in therapy will certainly follow.


2018 ◽  
Vol 2018 ◽  
pp. 1-8 ◽  
Author(s):  
Hong Zhong ◽  
Minjuan Ma ◽  
Tingming Liang ◽  
Li Guo

In all living organisms, metabolic homeostasis and the immune system are the most fundamental requirements for survival. Recently, obesity has become a global public health issue, which is the cardinal risk factor for metabolic disorder. Many diseases emanating from obesity-induced metabolic dysfunction are responsible for the activated immune system, including innate and adaptive responses. Of note, inflammation is the manifest accountant signal. Deeply studied microRNAs (miRNAs) have participated in many pathways involved in metabolism and immune responses to protect cells from multiple harmful stimulants, and they play an important role in determining the progress through targeting different inflammatory pathways. Thus, immune response and metabolic regulation are highly integrated with miRNAs. Collectively, miRNAs are the new targets for therapy in immune dysfunction.


2012 ◽  
Vol 8 (5) ◽  
pp. 401-403 ◽  
Author(s):  
Allison Nelson ◽  
Sajitha Nair ◽  
Srinivas Nagaraj

Author(s):  
Sijana H. Dzinic ◽  
Maria M. Bernardo ◽  
Daniel S.M. Oliveira ◽  
Marian Wahba ◽  
Wael Sakr ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document